The Discounted Cash Flow (DCF) valuation of Nuvo Pharmaceuticals Inc (MRV.TO) is (4.90) CAD. With the latest stock price at 1.35 CAD, the upside of Nuvo Pharmaceuticals Inc based on DCF is -462.9%.
Based on the latest price of 1.35 CAD and our DCF valuation, Nuvo Pharmaceuticals Inc (MRV.TO) is a sell. selling MRV.TO stocks now will result in a potential gain of 462.9%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 5.5% | 5.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (5.54) - 1.31 | (4.90) |
| Upside | -510.7% - -3.2% | -462.9% |